elotuzumab (empliciti) Report issue

Biologics mAb Orphan Drug FDA Approved FDA First in Class Priority Review FDA
Back

Drug Pricing Summary

VA Big4

$1422.6100 - $1909.3200

VA FSS

$1866.6500 - $2488.8600

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
elotuzumab 300 mg (INJECTION) $1422.6100 VA Big4
  • EMPLICITI (1)
  • Bristol-Myers Squibb Company
    elotuzumab 300 mg (INJECTION) $1866.6500 VA FSS
  • EMPLICITI (1)
  • Bristol-Myers Squibb Company
    elotuzumab 400 mg (INJECTION) $1909.3200 VA Big4
  • EMPLICITI (1)
  • Bristol-Myers Squibb Company
    elotuzumab 400 mg (INJECTION) $2488.8600 VA FSS
  • EMPLICITI (1)
  • Bristol-Myers Squibb Company

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue